KURA · Kura Oncology, Inc. · Investor Relations
$6.91
-0.44 (-5.99%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$634.88M
Shares
91.88M
Volume · Nov 20
1.75M
Avg daily vol (3M)
2.1M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-10 | Q3 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-10-13 | Kura Oncology EASD Virtual Investor Event | Event |
| 2026-09-16 | Morgan Stanley Global Healthcare Conference | Conference |
| 2026-09-09 | Cantor Global Healthcare Conference | Conference |
| 2026-08-12 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-07-27 | Kura Oncology KCRS Virtual Investor Event | Event |
| 2026-05-26 | TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA | Webcast |
| 2026-05-13 | 2026 Bank of America Securities Healthcare Conference | Conference |
| 2026-05-12 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-04-17 | Kura Oncology IKCS Virtual Investor Event | Event |
| 2026-03-05 | Earnings conference call (announced in 8-K) | Earnings call |
| 2025-11-13 | KOMZIFTI FDA Approval Call | Webcast |
| 2025-10-18 | Discussion of Clinical Data Presented at 2025 ESMO Congress, Including First Clinical Data from KO-2806, Kura’s Next-Generation FTI | Webcast |
Key facts
CIK
1422143
CUSIP
50127T109
13F (30d)
230 filings
211 filers
Visit website
Investor relations